معرفی
Stephan C Jahn is a Senior Lecturer and Program Director in the Department of Pharmacology and Therapeutics at the University of Florida. He holds a Ph.D. from the same department, focusing on cancer biology and in silico molecular docking for novel therapeutics. His research spans drug metabolism, drug resistance, and next-generation sequencing for lymphoma targets. Jahn coordinates online graduate programs while teaching across pharmacology, therapeutics, and molecular mechanisms at various academic levels.
Education: Ph.D. in Pharmacology from the University of Florida.
Research Interests: Jahn’s work integrates cancer biology with drug development, emphasizing age-related drug metabolism, mitochondrial enzyme regulation (GSTZ1), and anticancer agent repurposing. His recent studies explore dichloroacetate mechanisms, nicotinic receptor interactions, and miRNA-driven drug responses. He bridges basic science with educational innovation in medical pharmacology.
Publications: Jahn’s work highlights trends in drug metabolism (e.g., GSTZ1 modulation), anticancer therapies (dichloroacetate, tranexamic acid), and signaling pathways (Cdk2, p300 inhibitors). Key themes include age-dependent pharmacokinetics and combinatorial drug strategies for cancer treatment.
Advising & Grants: While no students are listed here, Jahn’s role focuses on program coordination rather than direct student supervision. His research has been supported by studies in pharmacology and therapeutics.
Labs/Teams: Active in the Pharmacology and Therapeutics department, contributing to drug discovery and educational program development.
